Free Trial

Abrdn Life Sciences Investors (HQL) Insider Trading & Ownership

Abrdn Life Sciences Investors logo
$13.78 -0.04 (-0.29%)
(As of 11/22/2024 ET)

Abrdn Life Sciences Investors (NYSE:HQL) Insider Buying and Selling Activity

Current
Insider Ownership
Percentage
10.06%
Number Of
Insiders Buying
(Last 12 Months)
23
Amount Of
Insider Buying
(Last 12 Months)
$6.20 M
Number Of
Insiders Selling
(Last 12 Months)
0
Get HQL Insider Trade Alerts

Want to know when executives and insiders are buying or selling Abrdn Life Sciences Investors stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily.

HQL Insider Buying and Selling by Quarter

Abrdn Life Sciences Investors Insider and Congressional Trades History

Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
8/23/2024Bill MaherDirectorBuy650$15.37$9,990.50  
7/16/2024Rose DimartinoDirectorBuy1,000$15.53$15,530.00  
6/26/2024Saba Capital Management, L.P.Major ShareholderBuy100$14.07$1,407.00  
6/24/2024Saba Capital Management, L.P.Major ShareholderBuy13,812$14.08$194,472.96  
6/12/2024Saba Capital Management, L.P.Major ShareholderBuy2,400$13.88$33,312.00  
6/10/2024Saba Capital Management, L.P.Major ShareholderBuy9,704$13.71$133,041.84  
6/6/2024Saba Capital Management, L.P.Major ShareholderBuy9,598$13.80$132,452.40  
6/4/2024Saba Capital Management, L.P.Major ShareholderBuy33,357$13.50$450,319.50  
5/30/2024Saba Capital Management, L.P.Major ShareholderBuy669$13.05$8,730.45  
5/28/2024Saba Capital Management, L.P.Major ShareholderBuy8,714$13.38$116,593.32  
5/23/2024Saba Capital Management, L.P.Major ShareholderBuy1,303$13.50$17,590.50  
5/15/2024Saba Capital Management, L.P.Major ShareholderBuy34,755$14.19$493,173.45  
5/10/2024Saba Capital Management, L.P.Major ShareholderBuy57,862$13.86$801,967.32  
5/8/2024Saba Capital Management, L.P.Major ShareholderBuy10,986$13.70$150,508.20  
5/6/2024Saba Capital Management, L.P.Major ShareholderBuy10,713$13.62$145,911.06  
5/2/2024Saba Capital Management, L.P.Major ShareholderBuy26,274$13.46$353,648.04  
4/30/2024Saba Capital Management, L.P.Major ShareholderBuy16,573$13.13$217,603.49  
4/26/2024Saba Capital Management, L.P.Major ShareholderBuy120,304$13.00$1,563,952.00  
4/24/2024Saba Capital Management, L.P.Major ShareholderBuy20,529$13.12$269,340.48  
4/22/2024Saba Capital Management, L.P.Major ShareholderBuy2,022$12.88$26,043.36  
4/18/2024Saba Capital Management, L.P.Major ShareholderBuy81,738$12.80$1,046,246.40  
4/9/2024Kathleen GoetzDirectorBuy400$13.32$5,328.00  
1/2/2024Todd ReitDirectorBuy1,000$13.80$13,800.00  
(Data available from 1/1/2013 forward)

HQL Insider Trading Activity - Frequently Asked Questions

The list of insiders at Abrdn Life Sciences Investors includes Bill Maher, Daniel R Omstead, Kathleen Goetz, Rose Dimartino, Saba Capital Management, L.P., and Todd Reit. Learn more on insiders at HQL.

10.06% of Abrdn Life Sciences Investors stock is owned by insiders. Learn more on HQL's insider holdings.

The following insiders have purchased HQL shares in the last 24 months: Bill Maher ($9,990.50), Daniel R Omstead ($277,249.44), Kathleen Goetz ($5,328.00), Rose Dimartino ($15,530.00), Saba Capital Management, L.P. ($6,156,313.77), and Todd Reit ($13,800.00).

Insiders have purchased a total of 486,559 HQL shares in the last 24 months for a total of $6,478,211.71 bought.

Abrdn Life Sciences Investors Key Executives

  • Dr. Daniel R. Omstead M.S (Age 71)
    Ph.D., Principal Executive Officer, President and Trustee
  • Mr. Peter Branner
    Chief Investment Officer


This page (NYSE:HQL) was last updated on 11/23/2024 by MarketBeat.com Staff
From Our Partners